IRD ▼ -4.9% - Opus Genetics, Inc.
$IRD - Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
16-OCT-2026 12:00 PM ET
Share this post
More filings for $IRD
IRD ▼ -1.2% - Opus Genetics, Inc.Oct 15, 2026IRD ▼ -0.2% - Opus Genetics, Inc.Oct 13, 2026IRD ▲ +37.0% - Opus Genetics, Inc.Sep 9, 2026IRD ▲ +7.2% - Opus Genetics, Inc.Sep 9, 2026IRD ▲ +0.5% - Opus Genetics, Inc.Sep 2, 2026IRD - Opus Genetics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $IRD filing history →💬 Comments
Loading comments…
Leave a comment